What is Ewings Sarcoma and who does it affect?
The Ewing’s family of tumors, originally described in 1921 by James Ewing, is of neural crest origin composed of small round cells. These tumors are vascular and often hemorrhagic in nature. Ewing’s sarcoma usually occurs in the mid-shaft of the long bones or in the flat bones of the trunk. It is a rare tumor with less than 200 new cases presenting each year in the United States and most commonly affects adolescents and young adults. On-set after the age of 40 is usually quite rare. 2. The ImmTher trial for Ewing’s sarcoma patients: The ImmTher clinical trial at the Children’s Cancer Hospital at the University of Texas M. D. Anderson Cancer Center is for newly diagnosed untreated patients with Ewing’s sarcoma who are at high-risk for relapse. This includes patients with metastatic disease at initial diagnosis, patients who have a primary tumor in the humerus, femur or in the trunk of the body, patients who present with tumors that are greater than 8 cm in size, and patients who have a
